The immune landscape of the hippocampus - the brain region most closely tied to learning and memory - appears to undergo a substantial changeover starting in midlife. In a study funded by the National Institutes of Health, researchers found that microglia, the brain's resident immune cells, gradually decline in number from roughly age 50 to age 75, and are replaced by cells that carry stronger inflammatory signals along with traits resembling immune cells that come from peripheral blood.
The work came from teams at the University of California, San Diego, the New York Genome Center and the University of California, Irvine, who applied advanced single-cell techniques to postmortem hippocampal tissue from 40 neurologically healthy adults spanning ages 20 to 95. Because all the donors were considered neurologically healthy, the shift the researchers documented looks like a feature of normal aging rather than a consequence of established disease.
That distinction is what makes the finding useful. Chronic brain inflammation is a familiar feature of neurodegenerative conditions, but it has been hard to say where it starts or why age raises risk so sharply. "Aging is the single largest risk factor for dementia, but our understanding of how it drives disease is still incomplete," said Richard Hodes, M.D., director of NIH's National Institute on Aging, who described the newly identified microglial shift as a possible clue toward completing that picture.
For now this is a description of a biological process, not a test or a treatment. Still, a change that begins around age 50 and unfolds over the following quarter century points to a long window in which the brain's immune environment is being reshaped - and gives researchers a specific cellular target to investigate as they try to explain how aging sets the stage for dementia.